Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Net product sales	$ 36,024	$ 31,762	$ 70,694	$ 61,377
Cost of product sales	10,518	20,158	18,962	37,012
Gross Profit	25,506	11,604	51,732	24,365
Operating expenses:
Research and development	4,432	13,210	9,040	22,046
General and administrative	13,905	19,592	28,879	35,426
Sales and marketing	13,614	21,205	25,056	42,359
Total operating expenses	31,951	54,007	62,975	99,831
Loss from operations	(6,445)	(42,403)	(11,243)	(75,466)
Other (expense) income, net	(2,790)	344	(1,152)	639
Net loss	(9,235)	(42,059)	(12,395)	(74,827)
Other comprehensive loss:
Unrealized (losses) gains on short-term investments	(2)	(15)	(21)	13
Comprehensive loss	$ (9,237)	$ (42,074)	$ (12,416)	$ (74,814)
Basic net loss per common share	$ (0.06)	$ (0.35)	$ (0.08)	$ (0.63)
Weighted average common shares outstanding, basic	152,305	119,719	151,900	119,484
Diluted net loss per common share	$ (0.06)	$ (0.35)	$ (0.08)	$ (0.63)
Weighted average common shares outstanding, diluted	152,305	119,719	151,900	119,484